Publications by authors named "Ann Dring"

Claim this Profile
D
Development and validation of blood-based diagnostic biomarkers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) using EpiSwitch 3-dimensional genomic regulatory immuno-genetic profiling.
Ewan Hunter, Heba Alshaker, Oliver Bundock, Cicely Weston, Shekinah Bautista, Ann Dring

J Transl Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood-Epigenetic Biomarker Associations with Tumor Immunophenotype in Patients with Urothelial Carcinoma from JAVELIN Bladder 100.
Thomas Powles, Srikala S Sridhar, Joaquim Bellmunt, Cora N Sternberg, Petros Grivas, Ann Dring

Cancers (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A New Blood-Based Epigenetic Diagnostic Biomarker Test (EpiSwitch NST) with High Sensitivity and Positive Predictive Value for Colorectal Cancer and Precancerous Polyps.
Ewan Hunter, Heba Alshaker, Cicely Weston, Mutaz Issa, Shekinah Bautista, Ann Dring

Cancers (Basel)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of Blood-Based Predictive Biomarkers for Response to PD-1/PD-L1 Checkpoint Inhibitors: Evidence of a Universal Systemic Core of 3D Immunogenetic Profiling across Multiple Oncological Indications.
Ewan Hunter, Matthew Salter, Ryan Powell, Ann Dring, Tarun Naithani

Cancers (Basel)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunological profile in cerebrospinal fluid of patients with multiple sclerosis after treatment switch to rituximab and compared with healthy controls.
Pierre de Flon, Lars Söderström, Katarina Laurell, Ann Dring, Peter Sundström

PLoS One· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS.
Joakim Bergman, Ann Dring, Henrik Zetterberg, Kaj Blennow, Niklas Norgren

Neurol Neuroimmunol Neuroinflamm· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced inflammation in relapsing-remitting multiple sclerosis after therapy switch to rituximab.
Pierre de Flon, Martin Gunnarsson, Katarina Laurell, Lars Söderström, Richard Birgander, Ann Dring

Neurology· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Levels and Age Dependency of Neurofilament Light and Glial Fibrillary Acidic Protein in Healthy Individuals and Their Relation to the Brain Parenchymal Fraction.
Mattias Vågberg, Niklas Norgren, Ann Dring, Thomas Lindqvist, Richard Birgander

PLoS One· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Assessment of the Prognostic Value of Biomarkers in Traumatic Brain Injury Reveals an Independent Role for Serum Levels of Neurofilament Light.
Faiez Al Nimer, Eric Thelin, Harriet Nyström, Ann M Dring, Anders Svenningsson

PLoS One· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination.
Faiez Al Nimer, Christina Elliott, Joakim Bergman, Mohsen Khademi, Ann M Dring

Neurol Neuroimmunol Neuroinflamm· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid depletion of B lymphocytes by ultra-low-dose rituximab delivered intrathecally.
Anders Svenningsson, Joakim Bergman, Ann Dring, Mattias Vågberg, Richard Birgander

Neurol Neuroimmunol Neuroinflamm· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intense inflammation and nerve damage in early multiple sclerosis subsides at older age: a reflection by cerebrospinal fluid biomarkers.
Mohsen Khademi, Ann M Dring, Jonathan D Gilthorpe, Anna Wuolikainen, Faiez Al Nimer

PLoS One· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatal neuroinflammation in a case of multiple sclerosis with anti-natalizumab antibodies.
Anders Svenningsson, Ann M Dring, Anna Fogdell-Hahn, Iwan Jones, Elin Engdahl

Neurology· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of constitutive androstane receptor (CAR) and pregnane X receptor (PXR) by 6-arylpyrrolo[2,1-d][1,5]benzothiazepine derivatives, ligands of peripheral benzodiazepine receptor (PBR).
Linnea E Anderson, Ann M Dring, Laura D Hamel, Matthew A Stoner

Toxicol Lett· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational quantitative structure-activity relationship (RQSAR) screen for PXR and CAR isoform-specific nuclear receptor ligands.
Ann M Dring, Linnea E Anderson, Saima Qamar, Matthew A Stoner

Chem Biol Interact· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-homologous end-joining gene profiling reveals distinct expression patterns associated with lymphoma and multiple myeloma.
Philippa L Roddam, James M Allan, Ann M Dring, Lisa J Worrillow, Faith E Davies

Br J Haematol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic evaluation of pathways associated with dexamethasone-mediated apoptosis and resistance in multiple myeloma.
Karen S Rees-Unwin, Rachel A Craven, Emma Davenport, Sarah Hanrahan, Nicholas F Totty, Ann M Dring

Br J Haematol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A global expression-based analysis of the consequences of the t(4;14) translocation in myeloma.
Ann M Dring, Faith E Davies, James A L Fenton, Philippa L Roddam, Kathryn Scott

Clin Cancer Res· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis.
Faith E Davies, Ann M Dring, Cheng Li, Andrew C Rawstron, Masood A Shammas

Blood· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymorphic variation in GSTP1 modulates outcome following therapy for multiple myeloma.
Ranjit K Dasgupta, Peter J Adamson, Faith E Davies, Sara Rollinson, Philippa L Roddam, Ann M Dring

Blood· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CYP1A1*2B (Val) allele is overrepresented in a subgroup of acute myeloid leukemia patients with poor-risk karyotype associated with NRAS mutation, but not associated with FLT3 internal tandem duplication.
David T Bowen, Marion E Frew, Sara Rollinson, Philippa L Roddam, Ann Dring

Blood· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic characterization of the chromosomal breakpoints of t(4;14) of multiple myeloma suggests more than one possible aetiological mechanism.
James A L Fenton, Guy Pratt, Andy C Rawstron, Kathryn Sibley, Dominic Rothwell, Ann Dring

Oncogene· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A molecular study of the t(4;14) in multiple myeloma.
Kathryn Sibley, James A L Fenton, Ann M Dring, Andrew J Ashcroft, Andrew C Rawstron

Br J Haematol· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis